M. Cannon

发表

Endemic Burkitt's lymphoma: a polymicrobial disease?

A. Moormann, R. Rochford, M. Cannon, 2005, Nature Reviews Microbiology.

Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice.

M. Cannon, 1987, Journal of virological methods.

Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus

B A Askonas, P. Openshaw, M. Cannon, 1988, The Journal of experimental medicine.

An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.

Bounleut Phanavanh, M. Cannon, M. D. Crew, 2005, Molecular immunology.

Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.

Shulin Li, Lijie Zhang, M. Torrero, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer.

T. O'brien, L. E. De Las Casas, S. Bellone, 2004, American journal of obstetrics and gynecology.

rAAV/Her-2/neu loading of dendritic cells for a potent cellular-mediated MHC class I restricted immune response against ovarian cancer.

Wei Zhou, J. Weidanz, K. Bumm, 2008, Viral immunology.

Epstein-Barr Virus Induced Lymphoproliferative Tumors in Severe Combined Immunodeficient Mice Are Oligoclonal

N. Cooper, P. Pisa, R. Fox, 2003 .

Racial differences in the overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in uterine serous papillary cancer.

E. Siegel, S. Bellone, A. Santin, 2005, American journal of obstetrics and gynecology.

In vitro induction of tumor-specific HLA class I-restricted CD8+ cytotoxic T lymphocytes from patients with locally advanced breast cancer by tumor antigen-pulsed autologous dendritic cells.

S. Bellone, A. Santin, M. Cannon, 2003, The Journal of surgical research.

Current treatment options for endometrial cancer

T. O'brien, S. Bellone, A. Santin, 2004, Expert review of anticancer therapy.

Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.

G. Parham, S. Bellone, A. Santin, 2002, International journal of radiation oncology, biology, physics.

Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.

G. Parham, P. Hermonat, S. Bellone, 2000, International journal of radiation oncology, biology, physics.

Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

A. Dietz, S. Weroha, M. Gustafson, 2020, Nature Communications.

Common and idiosyncratic patterns of cytokine gene expression by Epstein-Barr virus transformed human B cell lines.

D. Noonan, D. Mosier, R. Sabbe, 1997, Viral immunology.

Induction of tumour-specific CD8+ cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer

G. Parham, S. Bellone, A. Santin, 2002, British Journal of Cancer.

Expression of surface antigens during the differentiation of human dendritic cells vs macrophages from blood monocytes in vitro.

G. Parham, P. Hermonat, A. Santin, 1999, Immunobiology.

Immunological treatment of ovarian cancer

T. O'brien, A. Santin, M. Cannon, 2004, Current opinion in obstetrics & gynecology.

Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.

N. Cooper, R. Rochford, M. Cannon, 1993, Proceedings of the National Academy of Sciences of the United States of America.

Secretion of vascular endothelial growth factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix.

G. Parham, P. Hermonat, A. Santin, 1999, Obstetrics and gynecology.

Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy.

S. Bellone, A. Santin, S. Pecorelli, 2003, Gynecologic oncology.

Low Expression of CD 20 and CD 23 in Epstein-Barr Virus-Induced B Cell Tumors in SCIDIhu Mice

N. Cooper, M. Cannon, J. Garnier, 2007 .

Epstein-Barr Virus Induced Lymphoproliferative Tumors in Severe Combined Immunodeficient Mice Are Oligoclonal By Pave 1 Pisa

N. Cooper, R. Fox, M. Cannon, 2003 .

Skipping the two-step? Possible mechanisms of Epstein–Barr virus reactivation

R. Rochford, M. Cannon, 2003, Leukemia.

In vivo growth of Epstein-Barr virus transformed B cells with mutations in latent membrane protein 2 (LMP2)

R. Longnecker, K. Izumi, R. Rochford, 1997, Archives of Virology.

Epstein-Barr virus induced lymphoproliferative tumors in severe combined immunodeficient mice are oligoclonal.

N. Cooper, P. Pisa, R. Fox, 1992, Blood.

Epstein-Barr virus induces aggressive lymphoproliferative disorders of human B cell origin in SCID/hu chimeric mice.

N. Cooper, P. Pisa, R. Fox, 1990, The Journal of clinical investigation.

Dendritic Cells and Macrophages Are Productively Infected by Poliovirus

M. Chow, R. Wahid, M. Cannon, 2005, Journal of Virology.

Cytotoxic T-cell response to respiratory syncytial virus in mice

C. Bangham, M. Cannon, B. Askonas, 1985, Journal of virology.

Intrathecal cytotoxic T-cell immunotherapy for metastatic leptomeningeal melanoma.

L. Hutchins, G. Chatta, E. Angtuaco, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.

S. Bellone, A. Santin, S. Pecorelli, 2003, Gynecologic oncology.

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.

E. Goode, M. Block, K. Knutson, 2017, Cancer research.

Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model

Jia Liu, M. Cannon, Jason Liem, 2017, Molecular therapy oncolytics.

Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer

M. Cannon, Hannah E. Goyne, 2013, Front. Immunol..

Modulation of p38 MAPK signaling enhances dendritic cell activation of human CD4+ Th17 responses to ovarian tumor antigen

M. Chiriva-Internati, M. Cannon, E. Cobos, 2013, Cancer Immunology, Immunotherapy.

Phenotypic and Functional Analysis of Tumor-Infiltrating Lymphocytes Compared with Tumor-Associated Lymphocytes from Ascitic Fluid and Peripheral Blood Lymphocytes in Patients with Advanced Ovarian Cancer

G. Parham, P. Hermonat, S. Bellone, 2001, Gynecologic and Obstetric Investigation.

Induction of Ovarian Tumor‐Specific CD8+ Cytotoxic T Lymphocytes by Acid‐Eluted Peptide‐Pulsed Autologous Dendritic Cells

G. Parham, S. Bellone, A. Santin, 2000, Obstetrics and gynecology.

In vivo Safety and Immunoactivity of Oncolytic Jurona Virus in Hepatocellular Carcinoma: A Comprehensive Proteogenomic Analysis

Stephanie D. Byrum, Charity L. Washam, M. Borad, 2022, bioRxiv.

Restoration of Tumor-Specific HLA Class I Restricted Cytotoxicity in Tumor Infiltrating Lymphocytes of Advanced Breast Cancer Patients by in vitro Stimulation with Tumor Antigen-Pulsed Autologous Dendritic Cells

S. Bellone, A. Santin, M. Cannon, 2003, Breast Cancer Research and Treatment.

Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells.

G. Taylor, M. Cannon, B. Askonas, 1987, Immunology.

Preferential utilization of the perforin/granzyme pathway for lysis of Epstein-Barr virus-transformed lymphoblastoid cells by virus-specific CD4+ T cells.

A. Khanolkar, H. Yagita, M. Cannon, 2001, Virology.

Myeloma‐reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway

B. Barlogie, M. Chiriva-Internati, M. Cannon, 2001, British journal of haematology.

In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.

G. Parham, P. Hermonat, S. Bellone, 2000, American journal of obstetrics and gynecology.

Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer

T. O'brien, S. Bellone, A. Santin, 2004, BJOG : an international journal of obstetrics and gynaecology.

Restoration of tumor specific human leukocyte antigens class I‐restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

S. Bellone, A. Santin, S. Pecorelli, 2004, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Increased levels of interleukin‐10 and transforming growth factor‐β in the plasma and ascitic fluid of patients with advanced ovarian cancer

G. Parham, S. Bellone, A. Santin, 2001 .

Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer.

C. V. Smith, G. Parham, S. Bellone, 2001, BJOG : an international journal of obstetrics and gynaecology.

Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.

S. Bellone, A. Santin, S. Pecorelli, 2005, Current pharmaceutical design.

Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.

G. Parham, S. Bellone, A. Santin, 2002, The New England journal of medicine.

Functional diversity of the CD8(+) T-cell response to Epstein-Barr virus (EBV): implications for the pathogenesis of EBV-associated lymphoproliferative disorders.

R. Rochford, M. Cannon, M. Hobbs, 1998, Blood.

The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.

M. Block, K. Knutson, M. Cannon, 2019, Immunotherapy.

Further clinical advancement of dendritic cell vaccination against ovarian cancer.

M. Cannon, Lauren C. Morehead, 2018, Annals of research hospitals.

Dendritic cell vaccination against ovarian cancer – tipping the Treg/TH17 balance to therapeutic advantage?

M. Chiriva-Internati, M. Cannon, Hannah E. Goyne, 2011, Expert opinion on biological therapy.

Development and Therapeutic Effect of Adoptively Transferred T Cells Primed by Tumor Lysate-Pulsed Autologous Dendritic Cells in a Patient with Metastatic Endometrial Cancer

G. Parham, P. Hermonat, S. Bellone, 2000, Gynecologic and Obstetric Investigation.

Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen.

R. Pemberton, L. A. Ball, G. Wertz, 1987, The Journal of general virology.

Virus-Specific CD4+ and CD8+ Cytotoxic T-Cell Responses and Long-Term T-Cell Memory in Individuals Vaccinated against Polio

M. Chow, R. Wahid, M. Cannon, 2005, Journal of Virology.

Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.

M. Cannon, Hannah E. Goyne, P. Stone, 2011, Immunotherapy.

Recognition of respiratory syncytial virus fusion protein by mouse cytotoxic T cell clones and a human cytotoxic T cell line.

C. Bangham, M. Cannon, 1989, The Journal of general virology.

The characterization of monoclonal antibodies to Newcastle disease virus.

P. Russell, W. Russell, M. Cannon, 1983, The Journal of general virology.

A microwell immunoperoxidase test for screening hybridomas and for diagnosing Newcastle disease virus and Sendai virus.

P. Russell, M. Cannon, P. C. Griffiths, 1983, Journal of immunological methods.

Specificity of chicken secondary in vitro lymphoproliferative responses to a parakeet isolate of avian paramyxovirus-3.

P. Russell, M. Cannon, 1988, Avian pathology : journal of the W.V.P.A.

Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.

G. Parham, P. Hermonat, S. Bellone, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Induction of Human Papillomavirus-Specific CD4+ and CD8+ Lymphocytes by E7-Pulsed Autologous Dendritic Cells in Patients with Human Papillomavirus Type 16- and 18-Positive Cervical Cancer

G. Parham, P. Hermonat, A. Santin, 1999, Journal of Virology.

Restoration of tumor specific human leukocyte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocytes in patients with advanced ovarian cancer

S. Bellone, A. Santin, S. Pecorelli, 2003, International Journal of Gynecologic Cancer.

Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.

G. Parham, P. Hermonat, S. Bellone, 2001, Gynecologic oncology.

Biotin dependency due to a defect in biotin transport

M. Jennings, S. Cederbaum, J. Zempleni, 2002 .

Biotin dependency due to a defect in biotin transport.

M. Jennings, S. Cederbaum, J. Zempleni, 2002, The Journal of clinical investigation.

Secondary in vitro stimulation of specific cytotoxic cells to Newcastle disease virus in chickens.

P. Russell, M. Cannon, 1986, Avian pathology : journal of the W.V.P.A.

Human Papillomavirus Type 16 and 18 E7-Pulsed Dendritic Cell Vaccination of Stage IB or IIA Cervical Cancer Patients: a Phase I Escalating-Dose Trial

E. Siegel, S. Bellone, A. Santin, 2007, Journal of Virology.

HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.

S. Bellone, A. Santin, S. Pecorelli, 2006, Gynecologic oncology.

Advances in dendritic cell-based therapeutic vaccines for cervical cancer

S. Bellone, A. Santin, S. Pecorelli, 2007, Expert review of anticancer therapy.

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy

M. Borad, A. Basnakian, S. Post, 2022, bioRxiv.

Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages

Erich A. Peterson, M. Cannon, Jason Liem, 2022, bioRxiv.

Cellular immunotherapy for ovarian cancer

T. O'brien, M. Cannon, 2009, Expert opinion on biological therapy.

CD4+ T Cell-Induced Differentiation of EBV-Transformed Lymphoblastoid Cells Is Associated with Diminished Recognition by EBV-Specific CD8+ Cytotoxic T Cells 1

A. Khanolkar, R. Rochford, M. Cannon, 2003, The Journal of Immunology.

Interleukin-10 Increases Th1 Cytokine Production and Cytotoxic Potential in Human Papillomavirus-Specific CD8+ Cytotoxic T Lymphocytes

G. Parham, P. Hermonat, S. Bellone, 2000, Journal of virology.

Regulatory T Cells in Gynecologic Cancer.

M. Nakagawa, M. Cannon, Y. Ou, 2018, MOJ immunology.

Understanding the Cross-Talk between Ovarian Tumors and Immune Cells: Mechanisms for Effective Immunotherapies

M. Chiriva-Internati, M. Jenkins, M. Cannon, 2011, International reviews of immunology.

Induction of human tumor‐associated differentially expressed gene‐12 (TADG‐12/TMPRSS3)‐specific cytotoxic T lymphocytes in human lymphocyte antigen‐A2.1–positive healthy donors and patients with advanced ovarian cancer

T. O'brien, S. Anfossi, D. Silasi, 2009, Cancer.

Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.

T. O'brien, S. Anfossi, D. Silasi, 2009, American journal of obstetrics and gynecology.

Gastrointestinal tract dysbiosis enhances distal tumor progression through suppression of leukocyte trafficking.

E. Siegel, M. Robeson, R. Griffin, 2019, Cancer research.

Gene expression profiles of primary HPV16- and HPV18-infected early stage cervical cancers and normal cervical epithelium: identification of novel candidate molecular markers for cervical cancer diagnosis and therapy.

Erming Tian, Alexander Burnett, Eric R Siegel, 2005, Virology.

Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.

F. Grizzi, M. Chiriva-Internati, M. Jenkins, 2014, Gynecologic oncology.

Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats

G. Nemerow, M. Moore, M. Cannon, 1991, Journal of virology.

Functional Analysis of the CD4+ T-Cell Response to Epstein-Barr Virus: T-Cell-Mediated Activation of Resting B Cells and Induction of Viral BZLF1 Expression

M. Cannon, Zheng Fu, 2000, Journal of Virology.

Signaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated Macrophages

M. Cannon, S. Gujja, Debopam Ghosh, 2015, Vaccines.

Discrimination between uterine serous papillary carcinomas and ovarian serous papillary tumours by gene expression profiling

F. Zhan, J. Shaughnessy, E. Tian, 2004, British Journal of Cancer.

Overexpression of HER-2/neu in uterine serous papillary cancer.

G. Parham, T. O'brien, S. Bellone, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Cancer Testis Antigen Vaccination Affords Long-Term Protection in a Murine Model of Ovarian Cancer

C. Chapman, M. Chiriva-Internati, M. Jenkins, 2010, PloS one.

Cancer Testis Antigen, Ropporin, Is a Potential Target for Multiple Myeloma Immunotherapy

G. Bernardini, R. Gornati, M. Gioia, 2011, Journal of immunotherapy.

Influence of Allogeneic Blood Transfusion on Clinical Outcome during Radiotherapy for Cancer of the Uterine Cervix

G. Parham, S. Bellone, A. Santin, 2003, Gynecologic and Obstetric Investigation.

Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy

F. Zhan, J. Shaughnessy, S. Bellone, 2005, British Journal of Cancer.

Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy

Erming Tian, F. Zhan, J. Shaughnessy, 2004, International journal of cancer.

Characterization of Morreton Virus (MORV) as a Novel Oncolytic Virotherapy Platform for Liver Cancers

James M. Bogenberger, M. Barrett, R. Vile, 2022, bioRxiv.

Design of Gold Nanoparticles in Dendritic Cell‐Based Vaccines

K. B. Vang, M. Cannon, R. Dings, 2018, Particle & Particle Systems Characterization.

Protective CD8+ T-cell responses to cytomegalovirus driven by rAAV/GFP/IE1 loading of dendritic cells

W. Zhou, I. Dalle-Donne, A. Milzani, 2008, Journal of Translational Medicine.

Diminished recognition of HLA-A2 proteins lacking a cytoplasmic domain (CY) by A2-restricted, EBV-specific CTLs: possible role of the CY in TAP association

M. Cannon, V. Grigoriev, C. K. Osborn, 1999, Immunogenetics.

Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer

T. O'brien, A. Santin, M. Cannon, 2002, Expert review of anticancer therapy.

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trend

H. Coleman, M. Nakagawa, W. Greenfield, 2011, Cancer Immunology, Immunotherapy.

Definition of an Immunogenic Region Within the Ovarian Tumor Antigen Stratum Corneum Chymotryptic Enzyme

T. O'brien, A. Santin, M. Cannon, 2005, Clinical Cancer Research.

High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.

S. Bellone, A. Santin, S. Pecorelli, 2005, Gynecologic oncology.

0348: Phase I Dose Escalation Trial of Hpv16/18 E7-Pulsed Dendritic Cell Vaccination in Stage Ib-Iia Cervical Cancer Patients

S. Bellone, A. Santin, S. Pecorelli, 2006, International Journal of Gynecologic Cancer.

Identification of AKAP‐4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer

M. Chiriva-Internati, M. Cannon, L. Mirandola, 2012, The Prostate.

IdentificationofAKAP-4asaNewCancer/TestisAntigenfor DetectionandImmunotherapyofProstateCancer

M. Chiriva-Internati, M. Cannon, L. Mirandola, 2012 .

Secretion of vascular endothelial growth factor in ovarian cancer.

G. Parham, P. Hermonat, A. Santin, 1999, European journal of gynaecological oncology.

EBV human B-cell lymphomas in Scid mice: description of the model and study of the role of anti-CD40 and anti-CD23 monoclonal antibodies in their development.

N. Cooper, M. Cannon, J. Touraine, 1993, Transplantation proceedings.

T-cells in respiratory syncytial virus (RSV) infection.

P. Openshaw, M. Cannon, B. Askonas, 1989, Advances in experimental medicine and biology.

Low expression of CD20 and CD23 in Epstein-Barr virus-induced B cell tumors in SCID/hu mice.

N. Cooper, M. Cannon, J. Garnier, 1993, The American journal of pathology.

Ovarian Tumor Ascites CD14+ Cells Suppress Dendritic Cell–activated CD4+ T-cell Responses Through IL-10 Secretion and Indoleamine 2,3-Dioxygenase

M. Cannon, A. Burnett, Hannah E. Goyne, 2014, Journal of immunotherapy.

Recognition of a cervical cancer derived tumor cell line by a human papillomavirus type 16 E6 52-61-specific CD8 T cell clone.

M. Nakagawa, S. Bellone, A. Santin, 2006, Cancer immunity.

Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administration of Clostridium perfringens enterotoxin.

E. Siegel, S. Bellone, A. Santin, 2005, Cancer research.

The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer

Mao Zhang, K. Abbott, M. Cannon, 2017, The Journal of Biological Chemistry.

The case for HER2/neu as a therapeutic target for gynecologic malignancies.

M. Cannon, Hannah E. Goyne, 2012, Immunotherapy.

Myxoma virus lacking the host range determinant M062 stimulates cGAS-dependent type 1 interferon response and unique transcriptomic changes in human monocytes/macrophages

Erich A. Peterson, M. Cannon, Jason Liem, 2022, PLoS Pathogens.

Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers

James M. Bogenberger, M. Barrett, R. Vile, 2022, Hepatology.

IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.

E. Goode, M. Block, K. Knutson, 2017, Cancer research.

Cellular immunotherapy for ovarian cancer

T. O'brien, M. Cannon, 2009, Expert opinion on biological therapy.

Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade

B. Necela, K. Knutson, M. Cannon, 2023, Journal for ImmunoTherapy of Cancer.